The plasma soluble urokinase-type plasminogen activator receptor (suPAR) is a biomarker
for focal segmental glomerulosclerosis (FSGS), but its value is under discussion because of …

Background Acute kidney injury is frequently observed at the intensive care unit, after surgery,
and after toxic drug administration. A rise in serum creatinine and a fall in urine output are …

Background Immune-modulatory treatments have so far shown limited clinical activity in
primary brain tumours. We aimed to investigate soluble programmed death receptor ligand 1 (…

Acute kidney injury (AKI) is a leading complication in hospitalized patients of different disciplines
due to various aetiologies and is associated with the risk of chronic kidney disease, the …

Purpose In primary brain tumors, the efficacy of immune-modulating therapies is still under
investigation as inflammatory responses are restricted by tight immunoregulatory …

SARS-CoV-2 variants of concern (VOCs) have caused a significant increase in infections
worldwide. Despite high vaccination rates in industrialized countries, the fourth VOC, Omicron, …

Ablative fractional laser treatment facilitates epidermal drug delivery, which might be an
interesting option to increase the topical efficacy of biological drugs in a variety of dermatological …

Background The esophageal-tracheal Combitube (ETC) was developed for the management
of difficult airways but can also be used for general anaesthesia. Methods This clinical …

Acute kidney injury (AKI) is an abrupt deterioration of renal function often caused by severe
clinical disease such as sepsis, and patients require intensive care. Acute-phase parameters …

Background Critically ill patients in intensive care face hazardous conditions. Among these,
acute kidney injury (AKI) is frequently seen as a result of sepsis. Early diagnosis of kidney …